Dasatinib 20mg Tablets$55.00
1–9 boxes
$55.00 each
10–24 boxes
8% off
25+ boxes
10% off
Dasatinib 20mg Tablets
SKU GME1390Oncology Care
Product Introduction
Dasatinib 20mg is a targeted tyrosine-kinase inhibitor used for Philadelphia chromosome-positive chronic myeloid leukaemia and selected acute lymphoblastic leukaemia. Treatment is selected according to the cancer’s molecular findings.
How to use
Swallow the tablets whole, with or without food, at the same time each day. Proton-pump inhibitors and H2 blockers reduce absorption. Separate ordinary antacids by at least 2 hours before or after the dose.
How it works
Dasatinib blocks BCR-ABL and several related kinases that drive abnormal blood-cell growth. This suppresses the signals supporting leukaemia-cell survival.
Side effects
Low blood counts, diarrhoea, headache, rash and fluid retention can occur. Pleural effusion, serious bleeding and pulmonary arterial hypertension are important risks.
Important information
Blood counts, liver function and treatment response are monitored. Report persistent breathlessness, a new cough or swelling. Grapefruit and strong CYP3A-interacting medicines can alter exposure.
Uses
- Philadelphia chromosome-positive chronic myeloid leukaemia and selected Ph-positive acute lymphoblastic leukaemia.
Benefits
Can lower the leukaemia-cell burden and achieve measurable molecular responses during continuing treatment.
Why are BCR-ABL blood tests repeated?
They measure the molecular disease burden and help show whether treatment is producing the expected response.
Does a deep molecular response mean treatment can be stopped?
Not automatically. Treatment-free remission is considered only in carefully selected patients with a defined follow-up plan.
Why does the medicine affect stomach-acid treatment?
Dasatinib needs an acidic environment for reliable absorption. Suppressing stomach acid can substantially reduce the amount absorbed.
Can a temporary treatment break be part of care?
Yes. Blood-cell suppression or fluid-related problems can require a planned interruption or dose adjustment.
BCR-ABL: an abnormal protein that drives certain leukaemias. Molecular response: a reduction measured by a genetic blood test. Pleural effusion: fluid around a lung.; AR: Dasatinib 20mg أقراص; FR: Dasatinib 20mg comprimés; PT: Dasatinib 20mg comprimidos; ES: Dasatinib 20mg comprimidos; RU: Dasatinib 20mg таблетки; ID: Dasatinib 20mg tablet; VI: Dasatinib 20mg viên nén; MS: Dasatinib 20mg tablet; TL: Dasatinib 20mg mga tableta; ZH-SG: Dasatinib 20mg 片剂